Childhood acute lymphoblastic leukemia
- Childhood acute lymphocytic leukemia
- Pediatric acute lymphoblastic leukemia
- Childhood ALL
- Acute lymphoblastic leukemia/lymphoma
- Acute lymphoblastic leukemia
News & Events
Gene-Editing Tool Used to Treat Girl's Cancer
November 13, 2015
ORDR Co-Sponsored Conferences
2016 Rare Disease Day at NIH, Monday, February 29, 2016
Location: Building 10, Masur Auditorium, National Institutes of Health, Bethesda, MD
Description: The 2016 Rare Disease Day at NIH will take place on February 29. The event, sponsored by NCATS and the NIH Clinical Center, aims to raise awareness about rare diseases, the patients they affect and the research collaborations that are addressing rare disease challenges. The day will feature tours, posters and exhibits, and presentations.
Advancing Symptom Clusters Research on Rare Cancers, Wednesday, June 17, 2015
Location: NIH Neuroscience Building, Bethesda, MD
Description: <p>It is intended that the in-depth, interdisciplinary dialogue of this expert working group will formulate an emerging consensus on a working definition of symptom clusters and, specific gaps and opportunities that provide a foundation for a transformative strategic blueprint to guide future symptom cluster research in rare cancers. In addition, it is anticipated that workshop proceedings will inform a funding opportunity announcement.</p>
18th International RUNX Workshop, Sunday, August 14, 2011 - Wednesday, August 17, 2011
Location: Eleanor Roosevelt College, University of California, San Diego, La Jolla, CA
Description: Based on the long-standing interactive and inter-disciplinary traditions of the 17 previous RUNX workshops, the organizers anticipate that the 18th International RUNX Workshop will offer excellent opportunities for the cross-pollination of ideas and the development of new collaborations in this rapidly expanding field.
Overcoming Barriers to International Clinical Trials for Rare Cancers , Friday, December 10, 2010
Location: Bethesda, Maryland
Description: The goals of this conference were to introduce key institutional players to the topic of international clinical trials in rare cancers and to establish an ongoing dialogue. Participants left the meeting with a set of specific priorities that need to be enacted to promote these trials. The meeting promoted consensus on the way that resources are prioritized to address rare cancers. Participants were asked to convey the content of the meeting to their constituencies and to follow up with pilot concepts.
Immunotherapy in Pediatric Oncology: Progress and Challenges, Monday, October 11, 2010 - Tuesday, October 12, 2010
Location: Texas Children’s Hospital/Baylor College of Medicine, Houston, Texas
Description: Goals of this conference were to (1) enhance collaboration and cross-fertilization of ideas and approaches among this widely dispersed community; (2) provide opportunities for young immunotherapists to meet the “giants” in the field and thus enhance their careers; (3) provide the seeds for a collaborative network that would eventually represent a consortium of individuals working in this field, albeit focused on different pediatric tumors; and (4) bring together the community to address regulatory challenges in developing cell products for immune-based therapy, which will improve the efficiency of developing protocols that are acceptable to the Food and Drug Administration (FDA).
Etiology of cMyc Chromosomal Translocations, Friday, September 17, 2010
Location: Lipsett Auditorium, Bethesda, Maryland
Description: Workshop participants had an unprecedented opportunity to synthesize relevant functional, experimental, and human data on MYC-translocation to gain etiologic insight and provide direction for further research.